ZS Pharma, Inc. 4
4 · ZS Pharma, Inc. · Filed Dec 21, 2015
Insider Transaction Report
Form 4
ZS Pharma, Inc.ZSPH
Babler Martin
Director
Transactions
- Disposition to Issuer
Stock Options (NQ) - 2/5/15
2015-12-17−12,000→ 0 totalExercise: $46.86From: 2016-02-05Exp: 2025-02-04→ Common Stock (12,000 underlying) - Disposition to Issuer
Stock Options (NQ) - BOD 6/18/15
2015-12-17−4,000→ 0 totalExercise: $55.57From: 2016-06-18Exp: 2025-06-17→ Common Stock (4,000 underlying) - Disposition to Issuer
Common Stock
2015-12-17$90.00/sh−1,000$90,000→ 0 total
Footnotes (1)
- [F1]Includes 1,000 shares in the form of restricted stock units